• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

AcelRx Pharmaceuticals Inc

+ Add to Watchlist


5.437 EUR 0.150 2.68%

As of 09:50:03 ET on 08/29/2014.

Snapshot for AcelRx Pharmaceuticals Inc (R5X)

Open: 5.329 Day's Range: 5.303 - 5.437 Volume: 383
Previous Close: 5.587 52wk Range: 4.504 - 9.567 1-Yr Rtn: -27.26%

Stock Chart for R5X

No chart data available.
  • R5X:GR 5.437
  • 1D
  • 1M
  • 1Y
Interactive R5X Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for R5X

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.0750
Est. PEG Ratio -
Market Cap (M EUR) 235.84
Shares Outstanding (M) 43.38
30 Day Average Volume 420
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for R5X

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for R5X

AcelRx Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of acute and breakthrough pain. The Company's solutions are designed to provide mild sedation, anxiety reduction and pain relief for patients undergoing painful procedures in a physician's office.

Richard A KingPresident/CEO/Chief Commercial OfcrPamela P PalmerChief Medical Officer/Co-Founder
Timothy E Morris "Tim"Chief Financial OfficerLawrence G HamelChief Development Officer
More Company Profile & Key Executives for R5X

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil